Skip to main content
SMTI
NASDAQ Industrial Applications And Services

Sanara Sets September 30 Vote on $35/Share MiMedx Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$34.72
Mkt Cap
$319.1M
52W Low
$16.047
52W High
$35.95
52W Position info
116% above low
Off High info
3.4% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

SMTI has more than doubled off its 52-week low of $16.047 on elevated volume (2.3× avg).

Summary

Sanara MedTech filed its definitive proxy statement for the MiMedx acquisition, setting a September 30 shareholder vote and revealing 39% of shares are already committed to approve the deal.


Key Events · M&A and Partnerships · SMTI

  • Special Meeting Set for September 30

    Shareholders will vote on the MiMedx merger at a virtual meeting on September 30, 2026, with a record date of September 1, 2026 and 9,188,035 shares outstanding.

  • 39% of Shares Already Committed

    The Voting Agreement with Nixon-affiliated shareholders covers 39.0% of outstanding shares, significantly de-risking the approval threshold of a majority of outstanding shares.

  • HSR Waiting Period Expires September 11

    The antitrust waiting period under the HSR Act is set to expire on September 11, 2026, clearing a key regulatory hurdle before the shareholder vote.

  • $300M Debt Financing Committed

    MiMedx has a fully committed $300 million first lien senior secured term loan from Hayfin Capital Management to fund the cash portion of the $35.00 per share consideration.


Analysis · SMTI · Industrial Applications And Services

The definitive proxy statement locks in the shareholder vote date and reveals that 39% of shares are already committed to approve the deal via the Voting Agreement. With the HSR waiting period expiring September 11 and the Special Meeting set for September 30, the merger is on a clear path to close in Q4 2026. The $300 million Hayfin debt commitment removes financing risk, and the $22.5 million reverse termination fee protects Sanara shareholders if MiMedx fails to close.

How filings like this one have moved

In the 30 days to Sep 9, 2026, 36.4% of the 1919 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SMTI was trading at $34.72 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $319.1M. The 52-week trading range was $16.05 to $35.95. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SMTI - Latest Insights

SMTI
Aug 11, 2026, 5:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $34.12
Real-time Price: $35.10 info
Change: +$0.980 (+3%) info
Market Cap: $321.857M info
SMTI
Aug 11, 2026, 4:20 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $34.12
Real-time Price: $35.10 info
Change: +$0.980 (+3%) info
Market Cap: $321.857M info
SMTI
Aug 11, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.12
Real-time Price: $35.10 info
Change: +$0.980 (+3%) info
Market Cap: $321.857M info
SMTI
Jul 29, 2026, 4:24 PM EDT
Filing Type: 425
Importance Score:
10
Price at Filing: $30.25
Real-time Price: $35.10 info
Change: +$4.85 (+16%) info
Market Cap: $321.857M info
SMTI
Jul 29, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $32.69
Real-time Price: $35.10 info
Change: +$2.41 (+7%) info
Market Cap: $321.857M info